These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 21124766

  • 1. Epithelial cell transforming sequence 2 in human oral cancer.
    Iyoda M, Kasamatsu A, Ishigami T, Nakashima D, Endo-Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2010 Nov 29; 5(11):e14082. PubMed ID: 21124766
    [Abstract] [Full Text] [Related]

  • 2. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
    Takeuchi S, Kasamatsu A, Yamatoji M, Nakashima D, Endo-Sakamoto Y, Koide N, Takahara T, Shimizu T, Iyoda M, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    Biochem Biophys Res Commun; 2017 Apr 29; 486(2):385-390. PubMed ID: 28315328
    [Abstract] [Full Text] [Related]

  • 3. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
    Saito T, Kasamatsu A, Ogawara K, Miyamoto I, Saito K, Iyoda M, Suzuki T, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2015 Apr 29; 10(9):e0137923. PubMed ID: 26378920
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
    Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Bukawa H, Tanzawa H.
    PLoS One; 2013 Apr 29; 8(2):e56381. PubMed ID: 23418564
    [Abstract] [Full Text] [Related]

  • 5. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
    Yoshimura S, Kasamatsu A, Nakashima D, Iyoda M, Kasama H, Saito T, Takahara T, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
    Biochem Biophys Res Commun; 2017 Apr 15; 485(4):820-825. PubMed ID: 28257844
    [Abstract] [Full Text] [Related]

  • 6. Cavin-2 in oral cancer: A potential predictor for tumor progression.
    Unozawa M, Kasamatsu A, Higo M, Fukumoto C, Koyama T, Sakazume T, Nakashima D, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
    Mol Carcinog; 2016 Jun 15; 55(6):1037-47. PubMed ID: 26086332
    [Abstract] [Full Text] [Related]

  • 7. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
    Shimizu T, Kasamatsu A, Yamamoto A, Koike K, Ishige S, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2012 Jun 15; 7(9):e45510. PubMed ID: 23029062
    [Abstract] [Full Text] [Related]

  • 8. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ, Kuo CH, Chen SH, Lin CY, Lee YR.
    J Cell Mol Med; 2018 Mar 15; 22(3):1894-1908. PubMed ID: 29363886
    [Abstract] [Full Text] [Related]

  • 9. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
    Liu G, Ren X, Gao C, Zhang W.
    Mol Med Rep; 2015 Aug 15; 12(2):2225-30. PubMed ID: 25872568
    [Abstract] [Full Text] [Related]

  • 10. Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors.
    Poi MJ, Knobloch TJ, Sears MT, Uhrig LK, Warner BM, Weghorst CM, Li J.
    Anticancer Res; 2014 Jul 15; 34(7):3285-92. PubMed ID: 24982332
    [Abstract] [Full Text] [Related]

  • 11. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J, Ren Y, Zhang L, Kong X, Wang T, Shi Y, Bu R.
    PLoS One; 2017 Jul 15; 12(4):e0174309. PubMed ID: 28369091
    [Abstract] [Full Text] [Related]

  • 12. UNC93B1 promotes tumoral growth by controlling the secretion level of granulocyte macrophage colony-stimulating factor in human oral cancer.
    Wagai S, Kasamatsu A, Iyoda M, Hayashi F, Hiroshima K, Yoshimura S, Miyamoto I, Nakashima D, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
    Biochem Biophys Res Commun; 2019 May 21; 513(1):81-87. PubMed ID: 30935694
    [Abstract] [Full Text] [Related]

  • 13. Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells.
    Min R, Siyi L, Wenjun Y, Shengwen L, Ow A, Lizheng W, Chenping Z.
    Cancer Sci; 2012 Nov 21; 103(11):1938-45. PubMed ID: 22853846
    [Abstract] [Full Text] [Related]

  • 14. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
    Lin GJ, Huang YS, Lin CK, Huang SH, Shih HM, Sytwu HK, Chen YW.
    Clin Oral Investig; 2016 Apr 21; 20(3):533-40. PubMed ID: 26205068
    [Abstract] [Full Text] [Related]

  • 15. The epithelial cell transforming sequence 2, a guanine nucleotide exchange factor for Rho GTPases, is repressed by p53 via protein methyltransferases and is required for G1-S transition.
    Scoumanne A, Chen X.
    Cancer Res; 2006 Jun 15; 66(12):6271-9. PubMed ID: 16778203
    [Abstract] [Full Text] [Related]

  • 16. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
    Minakawa Y, Kasamatsu A, Koike H, Higo M, Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2013 Jun 15; 8(12):e85951. PubMed ID: 24386490
    [Abstract] [Full Text] [Related]

  • 17. IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.
    Gan CP, Sam KK, Yee PS, Zainal NS, Lee BKB, Abdul Rahman ZA, Patel V, Tan AC, Zain RB, Cheong SC.
    Cell Oncol (Dordr); 2019 Aug 15; 42(4):477-490. PubMed ID: 30949979
    [Abstract] [Full Text] [Related]

  • 18. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z, Wu X, Cao W, Shen Z, Wang L, Xie F, Zhang J, Ji T, Yan M, Chen W.
    J Exp Clin Cancer Res; 2014 Dec 18; 33(1):100. PubMed ID: 25539663
    [Abstract] [Full Text] [Related]

  • 19. Pituitary tumor‑transforming gene 1 regulates the senescence and apoptosis of oral squamous cell carcinoma in a p21‑dependent DNA damage response manner.
    Park S, Kim S, Kim MY, Lee SS, Choi J.
    Oncol Rep; 2024 Oct 18; 52(4):. PubMed ID: 39155881
    [Abstract] [Full Text] [Related]

  • 20. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
    Croucher DR, Rickwood D, Tactacan CM, Musgrove EA, Daly RJ.
    Mol Cell Biol; 2010 Nov 18; 30(21):5057-70. PubMed ID: 20805359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.